Literature DB >> 31397906

Muscle percentage index as a marker of disease severity in golden retriever muscular dystrophy.

Aydin Eresen1, Noor E Hafsa2, Lejla Alic2,3, Sharla M Birch4, John F Griffin4, Joe N Kornegay4, Jim X Ji1,2.   

Abstract

INTRODUCTION: Golden retriever muscular dystrophy (GRMD) is a spontaneous X-linked canine model of Duchenne muscular dystrophy that resembles the human condition. Muscle percentage index (MPI) is proposed as an imaging biomarker of disease severity in GRMD.
METHODS: To assess MPI, we used MRI data acquired from nine GRMD samples using a 4.7 T small-bore scanner. A machine learning approach was used with eight raw quantitative mapping of MRI data images (T1m, T2m, two Dixon maps, and four diffusion tensor imaging maps), three types of texture descriptors (local binary pattern, gray-level co-occurrence matrix, gray-level run-length matrix), and a gradient descriptor (histogram of oriented gradients).
RESULTS: The confusion matrix, averaged over all samples, showed 93.5% of muscle pixels classified correctly. The classification, optimized in a leave-one-out cross-validation, provided an average accuracy of 80% with a discrepancy in overestimation for young (8%) and old (20%) dogs. DISCUSSION: MPI could be useful for quantifying GRMD severity, but careful interpretation is needed for severe cases.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  DMD; GRMD; imaging biomarkers; machine learning; muscle percentage index; texture

Mesh:

Year:  2019        PMID: 31397906     DOI: 10.1002/mus.26657

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  1 in total

1.  MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma.

Authors:  Aydin Eresen; Jia Yang; Junjie Shangguan; Yu Li; Su Hu; Chong Sun; Yury Velichko; Vahid Yaghmai; Al B Benson; Zhuoli Zhang
Journal:  J Transl Med       Date:  2020-02-10       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.